These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23111389)

  • 21. miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2.
    Cho WJ; Shin JM; Kim JS; Lee MR; Hong KS; Lee JH; Koo KH; Park JW; Kim KS
    Mol Cells; 2009 Dec; 28(6):521-7. PubMed ID: 19937137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-106b-25 cluster targets β-TRCP2, increases the expression of Snail and enhances cell migration and invasion in H1299 (non small cell lung cancer) cells.
    Savita U; Karunagaran D
    Biochem Biophys Res Commun; 2013 May; 434(4):841-7. PubMed ID: 23611780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
    Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
    Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
    Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA
    Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.
    Li W; Wang L; Katoh H; Liu R; Zheng P; Liu Y
    Cancer Res; 2011 Mar; 71(6):2162-71. PubMed ID: 21278236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mir-629 Repressed LATS2 Expression and Promoted the Proliferation of Prostate Cancer Cells.
    Li Y; Zeng S; Cao L
    Horm Metab Res; 2023 Aug; 55(8):573-579. PubMed ID: 36990459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
    Peng H; Pan X; Su Q; Zhu LS; Ma GD
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2.
    Han LL; Yin XR; Zhang SQ
    Int J Oncol; 2018 Dec; 53(6):2433-2444. PubMed ID: 30272278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.
    Feng S; Pan W; Jin Y; Zheng J
    Tumour Biol; 2014 Dec; 35(12):12339-44. PubMed ID: 25179841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of miR-297b-5p protects against stearic acid-induced pancreatic β-cell apoptosis by targeting LATS2.
    Guo R; Yu Y; Zhang Y; Li Y; Chu X; Lu H; Sun C
    Am J Physiol Endocrinol Metab; 2020 Mar; 318(3):E430-E439. PubMed ID: 31961705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repression of MicroRNA-372 by Arsenic Sulphide Inhibits Prostate Cancer Cell Proliferation and Migration through Regulation of large tumour suppressor kinase 2.
    Cao H; Feng Y; Chen L
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):256-263. PubMed ID: 27730751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility.
    Zhuang M; Zhao S; Jiang Z; Wang S; Sun P; Quan J; Yan D; Wang X
    EBioMedicine; 2019 Mar; 41():286-298. PubMed ID: 30797712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Chen Z; Chu S; Liang Y; Xu T; Sun Y; Li M; Zhang H; Wang X; Mao Y; Loor JJ; Wu Y; Yang Z
    Food Funct; 2020 Oct; 11(10):8625-8636. PubMed ID: 32935676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway.
    Xin T; Lv W; Liu D; Jing Y; Hu F
    Aging (Albany NY); 2020 Jun; 12(12):12160-12174. PubMed ID: 32554853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.
    Png KJ; Halberg N; Yoshida M; Tavazoie SF
    Nature; 2011 Dec; 481(7380):190-4. PubMed ID: 22170610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
    Xia Y; Gao Y
    Biochem Biophys Res Commun; 2014 May; 447(3):446-51. PubMed ID: 24735543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
    Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
    EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway.
    Wang Z; Li TE; Chen M; Pan JJ; Shen KW
    Aging (Albany NY); 2020 Jan; 12(2):1867-1887. PubMed ID: 31986487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.
    Yao F; Liu H; Li Z; Zhong C; Fang W
    Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.